Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Allergy Thera. Share News (AGY)
AGY Share
Price
AGY Share
News
AGY Share
Chat
AGY Share
Trades18
AGY
Live RNS
AGY Share
Charts
AGY Level 2
Console
AGY Live
Share Price
AGY Broker
Ratings
AGY Directors
Deals
AGY Financial
Diary
AGY
Fundamentals
AGY Short
Positions
AGY
Media
AGY Company
Research
AGY Company
Timeline
Allergy Thera. Information
Share Price Information for Allergy Thera. (AGY)
Share Price is delayed by 15 minutes
Get Live Data
7.50
-0.40 (-5.06%)
Bid:
7.00
Ask:
8.00
Spread:
1.00 (14.286%)
Market Cap:
£474.94m
Last checked at -
Last checked at 
Intraday Allergy Thera. Share Chart
Allergy Thera. News
3 Mar 2021
Allergy Therapeutics reports record pre-R&D operating profit
(Sharecast News) - Commercial biotechnology company Allergy Therapeutics reported a 7% improvement in its revenue in actual terms in its interim resul...
13 Jan 2021
IN BRIEF: Allergy Therapeutics Hails Growth; Non-Exec Smith To Leave
IN BRIEF: Allergy Therapeutics Hails Growth; Non-Exec Smith To Leave
5 Jan 2021
IN BRIEF: Allergy Therapeutics And Imperial Start Peanut Allergy Study
IN BRIEF: Allergy Therapeutics And Imperial Start Peanut Allergy Study
5 Jan 2021
Allergy Therapeutics begins peanut allergy vaccine study
(Sharecast News) - Speciality allergy-focussed pharmaceutical company Allergy Therapeutics announced on Tuesday that an ex-vivo biomarker study of blo...
8 Dec 2020
IN BRIEF: Allergy Therapeutics Shareholders Revolt At General Meeting
IN BRIEF: Allergy Therapeutics Shareholders Revolt At General Meeting
1 Dec 2020
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
20 Nov 2020
UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth
UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth
26 Oct 2020
IN BRIEF: Allergy Therapeutics Kicks Off Grass Allergy Therapy Study
IN BRIEF: Allergy Therapeutics Kicks Off Grass Allergy Therapy Study
Follow the stocks
